Thomas Brett

Thomas Brett


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DKDaniel L. Kober
Daniel L. Kober
TBThomas Brett
Thomas Brett

20 December 2016 in eLife
Verified
Journal Article
Open access
DKDaniel L Kober
Daniel L Kober
TBThomas Brett
Thomas Brett
CKCeleste M Karch
Celeste M Karch
CCCarlos Cruchaga
Carlos Cruchaga
MCMarco Colonna
Marco Colonna
TBThomas Brett
Thomas Brett
Genetic variations in the myeloid immune receptor TREM2 are linked to several neurodegenerative diseases. To determine how TREM2 variants contribute to these diseases, we performed structural and functional studies of wild-type and variant proteins. Our 3.1 Å TREM2 crystal structure revealed that mutations found in Nasu-Hakola disease are buried whereas Alzheimer’s disease risk variants are found on the surface, suggesting that these mutations have distinct effects on TREM2 function. Biophysical and cellular methods indicate that Nasu-Hakola mutations impact protein stability and decrease folded TREM2 surface expression, whereas Alzheimer’s risk variants impact binding to a TREM2 ligand. Additionally, the Alzheimer’s risk variants appear to epitope map a functional surface on TREM2 that is unique within the larger TREM family. These findings provide a guide to structural and functional differences among genetic variants of TREM2, indicating that therapies targeting the TREM2 pathway should be tailored to these genetic and functional differences with patient-specific medicine approaches for neurodegenerative disorders.

17 March 2015 in eLife
Verified
Journal Article
Open access
MSMonica Sala-Rabanal
Monica Sala-Rabanal
ZYZeynep Yurtsever
Zeynep Yurtsever
CNColin G Nichols
Colin G Nichols
TBThomas Brett
Thomas Brett
Calcium-activated chloride channel regulator 1 (CLCA1) activates calcium-dependent chloride currents; neither the target, nor mechanism, is known. We demonstrate that secreted CLCA1 activates calcium-dependent chloride currents in HEK293T cells in a paracrine fashion, and endogenous TMEM16A/Anoctamin1 conducts the currents. Exposure to exogenous CLCA1 increases cell surface levels of TMEM16A and cellular binding experiments indicate CLCA1 engages TMEM16A on the surface of these cells. Altogether, our data suggest that CLCA1 stabilizes TMEM16A on the cell surface, thus increasing surface expression, which results in increased calcium-dependent chloride currents. Our results identify the first Cl− channel target of the CLCA family of proteins and establish CLCA1 as the first secreted direct modifier of TMEM16A activity, delineating a unique mechanism to increase currents. These results suggest cooperative roles for CLCA and TMEM16 proteins in influencing the physiology of multiple tissues, and the pathology of multiple diseases, including asthma, COPD, cystic fibrosis, and certain cancers.

1 December 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ZYZeynep Yurtsever
Zeynep Yurtsever
MSMonica Sala-Rabanal
Monica Sala-Rabanal
DRDavid T. Randolph
David T. Randolph
SSSuzanne M. Scheaffer
Suzanne M. Scheaffer
WRWilliam T. Roswit
William T. Roswit
TBThomas Brett
Thomas Brett
The chloride channel calcium-activated (CLCA) family are secreted proteins that regulate both chloride transport and mucin expression, thus controlling the production of mucus in respiratory and other systems. Accordingly, human CLCA1 is a critical mediator of hypersecretory lung diseases, such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, that manifest mucus obstruction. Despite relevance to homeostasis and disease, the mechanism of CLCA1 function remains largely undefined. We address this void by showing that CLCA proteins contain a consensus proteolytic cleavage site recognized by a novel zincin metalloprotease domain located within the N terminus of CLCA itself. CLCA1 mutations that inhibit self-cleavage prevent activation of calcium-activated chloride channel (CaCC)-mediated chloride transport. CaCC activation requires cleavage to unmask the N-terminal fragment of CLCA1, which can independently gate CaCCs. Gating of CaCCs mediated by CLCA1 does not appear to involve proteolytic cleavage of the channel because a mutant N-terminal fragment deficient in proteolytic activity is able to induce currents comparable with that of the native fragment. These data provide both a mechanistic basis for CLCA1 self-cleavage and a novel mechanism for regulation of chloride channel activity specific to the mucosal interface.

1 January 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSMelissa Swiecki
Melissa Swiecki
SSSuzanne M. Scheaffer
Suzanne M. Scheaffer
MAMarc Allaire
Marc Allaire
DFDaved H. Fremont
Daved H. Fremont
MCMarco Colonna
Marco Colonna
TBThomas Brett
Thomas Brett
BST-2/tetherin is a host antiviral molecule that functions to potently inhibit the release of enveloped viruses from infected cells. In return, viruses have evolved antagonists to this activity. BST-2 traps budding virions by using two separate membrane-anchoring regions that simultaneously incorporate into the host and viral membranes. Here, we detailed the structural and biophysical properties of the full-length BST-2 ectodomain, which spans the two membrane anchors. The 1.6-Å crystal structure of the complete mouse BST-2 ectodomain reveals an ∼145-Å parallel dimer in an extended α-helix conformation that predominantly forms a coiled coil bridged by three intermolecular disulfides that are required for stability. Sequence analysis in the context of the structure revealed an evolutionarily conserved design that destabilizes the coiled coil, resulting in a labile superstructure, as evidenced by solution x-ray scattering displaying bent conformations spanning 150 and 180 Å for the mouse and human BST-2 ectodomains, respectively. Additionally, crystal packing analysis revealed possible curvature-sensing tetrameric structures that may aid in proper placement of BST-2 during the genesis of viral progeny. Overall, this extended coiled-coil structure with inherent plasticity is undoubtedly necessary to accommodate the dynamics of viral budding while ensuring separation of the anchors.

8 October 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
DKDaniel L. Kober
Daniel L. Kober
MSMelissa D. Stuchell‐Brereton
Melissa D. Stuchell‐Brereton
CKColin E. Kluender
Colin E. Kluender
HDHunter B. Dean
Hunter B. Dean
MSMichael R. Strickland
Michael R. Strickland
TBThomas Brett
Thomas Brett